Le français est une traduction alpha automatisée. Pour le texte officiel, consultez la version anglaise.

Explorateur d’archives

Parcourir et rechercher des captures

Note importante

Parcourez et recherchez des captures historiques. Ceci est une archive — pas des directives actuelles ni un avis médical. Le contenu archivé peut être incomplet, périmé ou remplacé. Pour des recommandations à jour, consultez toujours le site officiel de la source.

Pour plus de contexte sur la couverture et les méthodes de capture, voir Méthodes et couverture.

Parcourir les sites archivés

Parcourir toutes les sources →

DSEN Abstract Comparative effectiveness of influenza vaccines in elderly persons Influenza-related complications can lead to hospitalizations and death in seniors Influenza vaccine immunogenicity (antibody response) is lower in seniors vs. those younger Determining the most…

DSEN Abstract Cough and Cold Products Containing Opioids: Prescribing and Patient Utilization Patterns in the Pediatric Population A Health Canada signal assessment led to advisement that children should not use these products to avoid opioid-related risks Knowing prescription…

DSEN Abstract: Safety and effectiveness of influenza vaccine during pregnancy - CIHR

Canadian Institutes of Health ResearchCaptures 83Dernière capture 2 mai 2026en

DSEN Abstract Safety and effectiveness of influenza vaccine during pregnancy This research was funded by the Drug Safety and Effectiveness Network (DSEN) and conducted by the following investigators: Anick Bérard, Vanina Tchuente, Sasha Bernatsky, William Fraser, Caroline Quach.…

DSEN Abstract Drugs for the Treatment and Prevention of Osteoporosis in Post-menopausal Women: A Systematic Review and Network Meta-analysis Summary We conducted a comprehensive systematic review and network meta-analysis to summarize the comparative benefits and harms of oral…

DSEN Abstract SGLT2 Inhibitors and the Risk of Diabetic Ketoacidosis: A study conducted by the Canadian Network for Observational Drug Effect Studies (CNODES) Summary SGLT2 inhibitor use was associated with an increased risk of DKA compared to DPP-4 inhibitors among patients with…

DSEN Abstract Active Surveillance & Canadian multi-province Cohorts of Pregnant Women and Children The CAMCCO infrastructure leads to fast-track, valid and reproducible real-world evidence for decision making, and clinical practice guidelines, including identifying serious events…

DSEN Abstract SGLT2 Inhibitors and the Risk of Major Adverse Cardiovascular Events A study conducted by the Canadian Network for Observational Drug Effect Studies (CNODES) SGLT2 inhibitor use was associated with a decreased risk of serious cardiovascular events compared with the…

DSEN Abstract: SGLT2 Inhibitors and the Risk of Severe Urinary Tract Infection - CIHR

Canadian Institutes of Health ResearchCaptures 83Dernière capture 2 mai 2026en

DSEN Abstract SGLT2 Inhibitors and the Risk of Severe Urinary Tract Infection A study conducted by the Canadian Network for Observational Drug Effect Studies (CNODES) SGLT2 inhibitor use was not associated with an increased risk of severe UTI compared to use of DPP-4 inhibitors…

DSEN Abstract: SGLT2 Inhibitors and the Risk of Below-Knee Amputation - CIHR

Canadian Institutes of Health ResearchCaptures 83Dernière capture 2 mai 2026en

DSEN Abstract SGLT2 Inhibitors and the Risk of Below-Knee Amputation A study conducted by the Canadian Network for Observational Drug Effect Studies (CNODES) What is the issue? Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a new class of drugs used in the second- or…

Page 273 sur 6399Affichage de 2721 à 2730 sur 63986

Version préliminaire : la couverture et les fonctionnalités sont encore en expansion.